Below is the PowerPoint presentation given by ERICA.
The ERICA study is a large randomised controlled cancer trial with 477 practices taking part.
Aim is to assess the clinical effectiveness of cancer electronic Risk Assessment Tools (eRATs) in diagnosing cancer earlier (stages 1 and 2)
Comparing the stage of cancers diagnosed in practices using the Skyline cancer tools (intervention) to practices not using eRATs/Skyline (controls)
Hoping to see a 4-5% increase in the proportion of early-stage cancers diagnosed if the eRATs intervention is successful
6 cancers: Bladder, Kidney, Lung, Colorectal, Ovarian and Oesophago-gastric
The Skyline eRATs:
Generate a pop-up when a patient record is open and if Skyline detects a 2+% risk of cancer
Risk score is displayed but not recorded on patient record (is only for patients aged 40+).
Clinicians decide next course of action
Symptom checker function for exploring possibility of cancer further in consultation with patient
New symptoms can be added into the symptom checker, allowing recalculation of the risk of cancer
Skyline works on coded medical records (not free-text)
The main trial is now halfway through its 2-year data collection phase (ends March 2024)